Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.

Core Evid · 2006 · PMC3321663 · PMID 22500153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

(2005) have reported a nonsignificant trend towards reduced duration of treatment relative to vancomycin/aztreonam when patients with complicated SSSIs were treated with tigecycline ( Table 8 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.